Press releases

Turkish patent office issues first Topical Nimesulide Patent for SULIDIN® under the title 'Nimesulide containing topical formulations'. More

Reddy US Therapeutics, Inc a biopharmaceutical company in suburban Atlanta, and a subsidiary of Dr. Reddy's Laboratories Limited announced today the appointment of Dr. Bruce Carter to its Board of Directors More

Reddy US Therapeutics, Inc a biopharmaceutical company in suburban Atlanta, and a subsidiary of Dr. Reddy's Laboratories Limited, announced the acceptance of two separate abstracts to be presented at the upcoming 61st Annual Scientific Sessions of th More

Nimesulide as the "COX-2 inhibitor that spares COX-1", but with additional activities that are not common to the other NSAIDs ("COX-2 and beyond"activity). More

A brainstorming session on the NSAID, Nimesulide, was organised at the Splendid Hotel in Lugano on 28th May 2001 by Helsinn Healthcare S.A., Switzerland, worldwide licensor of the drug. More